We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX slides 24.6 points with 10 of 11 sectors lower Materials sector squeaks into green on gold gain...
Read ArticleManufacturing completed on Imagion’s MagSense HER2 breast cancer imaging agent for its Phase II cli...
Read ArticleAfter five months of consecutive gains, the ASX 200 fell 0.78% in September with nine of 11 sectors...
Read ArticleCurrent cancer imaging tools are “not good enough”, Imagion chief Bob Proulx says Micro-x announces...
Read ArticleDown, down, prices were down for the ASX this week … but TFFF (Thank something for Friday) as we re...
Read ArticleGood afternoon, and welcome to the HotCopper HotList Top 10. Every week, hundreds of companies go th...
Read ArticlePitt Street Research says Imagion is significantly undervalued and sits around 75-80% below target...
Read ArticleCervical cancer detection play Truscreen says its year is off to a good start PYC Therapeutics ente...
Read ArticleASX closes 0.24% lower on Monday with tech leading gainers and energy the laggards Asian markets cl...
Read ArticleImagion Biosystems (ASX: IBX) has commenced manufacturing of its MagSense imaging agent ahead of a P...
Read ArticleImagion Biosystems (ASX:IBX) has started manufacturing its MagSense HER-2 imaging agent ahead of a P...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleDimerix boss Dr Nina Webster to join Imagion Biosystems as non-executive director Webster has exten...
Read ArticleIn the medical device sector, sometimes trial news can excite investors more than the approval en...
Read ArticleImagion to collaborate with MRI experts at Wayne State University to strengthen push into AI-enable...
Read ArticleImugene and Chimeric have unveiled further promising results for their Car-T immune-oncology assets...
Read ArticleStockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of th...
Read ArticleImagion secures $3.5 million in capital raise to sophisticated investors and family offices Placeme...
Read ArticleCopper prices crash 20pc Materials sector undercuts market, down 2.57pc Info tech rally not enough...
Read ArticlePlenty of biotechs are lodging late in the piece, but without too many ‘dog ate my homework’ excus...
Read ArticleASX hits new record closing high of 8630 points Broad strength across 10 of 11 sectors, led by info...
Read ArticleImagion Biosystems (ASX: IBX) has announced it will fast-track a new batch of MagSense HER2 imaging...
Read ArticleImagion holds positive meeting with senior US FDA staff on planned Phase II clinical trial for HER2...
Read ArticleMorning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the...
Read ArticleASX shrugs off tariff pessimism to climb 0.59pc Gains led by gold and banking stocks Major banks jo...
Read ArticleTrigg Minerals (ASX:TMG) has drawn the most attention on the HotCopper forums through Thursday trade...
Read ArticleImagion receives positive feedback from US FDA for HER2 breast cancer phase II clinical trial The c...
Read ArticleAI is reshaping microbiology in the labs Big Pharma taps Clever Culture’s APAS system Here are ASX...
Read ArticleCertain ASX-listed medtech companies are delivering technologies that enhance clinical precision, s...
Read ArticleStockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of th...
Read ArticleStockhead’s Fraser Palamara chats with Imagion Biosystems (ASX:IBX) executive chairman Robert Proulx...
Read ArticleA number of ASX-listed healthcare companies, many with relatively low market caps, are making strid...
Read ArticleCancer detection specialist Imagion Biosystems (ASX: IBX) has taken the next step in progressing its...
Read ArticleManufacturing to start on new batch of Imagion’s MagSense HER2 breast cancer imaging agent The new...
Read ArticleEarly detection and treatment can improve prognosis for cancer patients Several ASX biotechs lookin...
Read ArticleImagion Biosystems to use funds from $3m capital raise to advance MagSense platform technology Thro...
Read ArticleCancer drug developer Chimeric Therapeutics eyes minimum $5 million raising ‘The next Telix’, Clari...
Read ArticleASX gains as energy and mining stocks rally Arcadium Lithium surges after Rio acquisition, while...
Read ArticleImagion raises $3 million to advance its MagSense platform MagSense is designed to revolutionise c...
Read ArticleASX fell as mining stocks dropped on China’s lack of stimulus Brent oil dipped below US$80 Big lit...
Read ArticleGood morning! ASX futures were up 0.28 per cent at 8:30 am AEDT after a fairly uninspiring US sessio...
Read ArticleAn already buoyant ASX boosted past +1.1% on happy CPI data for May. Consumer Discretionary just pi...
Read Article“I am thrilled to be leading the Imagion team and look forward to driving the company’s cont...
Read ArticleAussie markets are down 0.6% after the gubbermint dropped an unpopular look at the future. Gold sto...
Read ArticleThe ASX closed 0.6 per cent lower on news Australia is likely to be hit with a mid-year slowdown....
Read ArticleStockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have sl...
Read ArticleThe ASX is tracking negatively so far, down by 0.3 per cent at midday, with the biggest gainers bein...
Read ArticleOffice and industrial property group, Dexus (ASX:DXS), has reduced the book value of its office and...
Read ArticleSayona Mining (ASX:SYA) announced that their preliminary technical study at their NAL lithium carb...
Read Article21 Jun 2023 - A snapshot of the stocks on the move featuring Sayona Mining (ASX:SYA), Tamboran Resou...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleImagion Biosystems (IBX) will close its MagSense HER2 imaging agent phase one clinical study after a...
Read ArticleThe ASX is set to retreat after Wall Street’s momentum fades KKR agrees to buy Paypal’s BNPL portfo...
Read ArticleAt the start of a new trading week, the ASX is expected to open slightly lower, reflecting the losse...
Read ArticleImagion Biosystems (IBX) deepens its annual loss by 62.8 per cent for the year ending December 31, 2...
Read ArticleShareCafeWebinar Recap – PFG, IBX, EMD & ATC Catch up on the full webinar with presentations...
Read ArticleShareCafeImagion Biosystems (ASX: IBX) – Webinar Presentation Bob Proulx CEO – Imagion Biosystems a...
Read ArticleTim Boreham reports Imagion's CEO believes the oncology imaging innovator has achieved far more with...
Read ArticleShareCafeProperty sector leads ASX 0.3% lower by Peter Milios Large property players Goodman Group...
Read ArticlePsychedelic drugs remain the talk of an otherwise depressed market today Newmont bid for Newcrest h...
Read ArticleImagion Biosystems (IBX) announces a positive outcome from an independent review of its MagSense HER...
Read Article06 Feb 2023 - A snapshot of the stocks on the move featuring Newcrest Mining (ASX:NCM), Imagion Bios...
Read ArticleShareCafeASX 0.1% lower at noon after all US indices fell over the weekend by Peter Milios At noon...
Read ArticleShareCafeStocks of the Hour: NCM, IBX, EMD Newcrest Mining (ASX:NCM) has co...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleImagion Biosystems (IBX) reported positive findings for its phase one HER2 breast cancer study over...
Read ArticleShareCafeLithium slammed by GS, NSW close to energy deal with Federal Government: ASX closes 0.6% lo...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Cancer detection technology...
Read ArticleShareCafeLithium stocks under pressure following Goldman’s comments: ASX down 0.47% at noon by Laure...
Read ArticleShareCafeStocks of the Hour: CZN, SOP, IBX Corazon Mining (ASX:CZN) has dis...
Read Article08 Dec 2022 - A snapshot of the stocks on the move featuring Corazon Mining (ASX:CZN), Synertec Corp...
Read ArticleImagion presents positive data at world leading symposium Osteopore expands in Southeast Asia Micro...
Read Article08 Dec 2022 - A snapshot of the stocks on the move featuring Corazon Mining (ASX:CZN), Synertec Corp...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleImagion Biosystems (IBX) reports evidence in human patients that its MagSense cancer detection tech...
Read ArticleThe ASX is set to fall for a third consecutive day Tech stocks dragged Wall Street down overnight,...
Read ArticleASX-listed Imagion Biosystems (IBX) is bringing groundbreaking nanotechnology to the world of health...
Read ArticleImagion Biosystems (IBX) progressed research and development activities for its MagSense cancer dete...
Read ArticleRobert Proulx of Imagion Biosystems speaks at the Switzer Small and Micro Cap Investor Strategy Day...
Read ArticleImagion Biosystems (IBX) is set to present its prostate cancer research at the 2022 World Molecular...
Read ArticleImagion Biosystems (IBX) increases its operational spending during the half year as it aims to expa...
Read ArticleHighlights Wellnex Life has signed a supply agreement with GSK CTS for its innovative soft gel l...
Read ArticleHighlights Imagion Biosystems marks significant progress in its first-in-human study for the...
Read ArticleThe Emerging Companies Index (XEC) climbed more than 2% higher on Thursday, before closing at 1.9%,...
Read ArticleThe share market sealed its best two-day advance in six weeks as unemployment hit a 14-year low and...
Read ArticleHighlights The Australian market opened on a cheerful note today tracking Wall Street’s positive...
Read ArticleThe Imagion Biosystems Ltd (ASX: IBX) share price is rebounding strongly after weeks of severe fall...
Read ArticleThe share market flew to a one-month high after unemployment fell to its lowest since 2008 and the F...
Read ArticleHighlights The benchmark ASX 200 index surged 1.16% to 7,258 in the first 15 minutes of trading....
Read ArticleImagion Biosystems (IBX) receives positive results from its first-in-human study for the MagSense H...
Read ArticleThe ‘Covid-induced trial, interrupted syndrome’ is no more apparent than within the walls of Imagion...
Read ArticleMichael Gable is an expert guest commentator for the Finance News Network, presenting “Stock Watch”...
Read ArticleThe Imagion Biosystems Ltd (ASX: IBX) share price is taking off following the release of the compan...
Read ArticleLeader of the ASX health stocks today is Imugene (ASX:IMU) up 4.11% after announcing plans to presen...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleLarge and small caps had diverging fates on the ASX today with the former closing 0.32 per cent down...
Read ArticleThe Imagion Biosystems Ltd (ASX: IBX) share price is rebounding strongly after weeks of severe fall...
Read ArticleSummary The RLC share price has shot up by a massive 68.7% to AU$0.027 in today’s session. Mosa...
Read ArticleFor all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t chang...
Read ArticleSummary Medicinal cannabis player Botanix Pharmaceuticals Limited has provided a clinical develo...
Read ArticleFunds management administration company Mainstream Group (ASX:MAI) topped the Running Hot list with...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleThe Imagion Biosystems Ltd (ASX: IBX) share price has rocketed 1,166% over the past 12 months due t...
Read ArticleImagion Biosystems CEO Robert Proulx speaks at the Switzer Small and Micro Cap Virtual Investor Day...
Read ArticleYesterday we dwelled on the notion that China’s aggressive trade tactics against Australia are in re...
Read ArticleBy Peter Switzer, Switzer Report Lots of smaller companies I like One thing I’ve personally learnt t...
Read ArticleThe capital raising wave shows no sign of crashing with August’s total coming in at $4.7bn. Once aga...
Read ArticleA quick wrap of the ASX’s key winners and losers on Thursday, August 13. Data is taken after the mar...
Read ArticleA quick wrap of the ASX’s key winners and losers on Wednesday, August 12. Data is taken after the ma...
Read ArticleA quick wrap of the ASX’s key winners and losers on Wednesday, July 22. Data is taken after the mark...
Read ArticleResearch by the University of Sydney has demonstrated that iron oxide nanoparticles developed by Ima...
Read ArticleNew research indicates Imagion Biosystems’ (ASX: IBX) imaging particles could bring down Tesla — in...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleA quick wrap of the key winners and losers on Monday, July 6. Data is taken after the market closes...
Read ArticleHealth Minister Greg Hunt has revived a long-standing plan to turn Australia into a “one stop shop”...
Read ArticlePitt Street Research sees a re-rating on the cards for Imagion Biosystems, which has secured strong...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small ca...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleCancer detection company Imagion Biosystems (ASX: IBX) has signed a collaboration agreement with glo...
Read ArticleParticipating in small cap raises is proving lucrative for investors, with shares in 47 small caps t...
Read ArticleA quick wrap of the key winners and losers on Tuesday, May 12. Data is taken after the market closes...
Read ArticleImagion Biosystems (ASX:IBX) has announced the appointment of Dianne Angus to its board of d...
Read ArticleIt’s still a relatively difficult market to raise capital in, particularly at the junior end, but th...
Read ArticlePeter Switzer is joined by the CEO of medical imaging company Imagion Biosystems (IBX), Robert Proul...
Read ArticleMelbourne-based Imagion Biosystems (ASX: IBX), a company focused on the earlier detection of...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleWhile investing in the stock market, an investor comes across various classes of assets, such as equ...
Read ArticleIn the Australian health care system, three levels of government are responsible for providing unive...
Read ArticleFor a certain generation of investors the word ‘laser’ is indelibly tied to a Dr Evil reference. Ove...
Read ArticleWith over 40 years’ experience in the healthcare diagnostic imaging industry, Imagion Biosystems (AS...
Read ArticleImagion Biosystems Limited (ASX:IBX), a company dedicated to improving healthcare through the earlie...
Read ArticleMedical devices are one of an essential parts of health care system. These are used for accurate dia...
Read ArticleToday is the deadline for firms to lodge their quarterly reports. These are the small cap companies...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and pickin...
Read ArticleMedicinal cannabis stock Althea (ASX:AGH) had a mixed bag of news for investors in its market update...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleImagion Biosystems: Breakthrough Device By Pitt Street Research An innovative medical device company...
Read ArticleInterview with Bob Proulx, CEO Imagion Biosystems By Pitt Street Research Imagion Biosystems: Breakt...
Read ArticleASX code: IBX Market cap: $12.95m Share price: 4c Shares on issue: 323,705,324 Chairman and CEO: Bob...
Read ArticleIn light of the volatility that has rocked global equities markets including the ASX, Finfeed felt i...
Read ArticleEvent: Possible MRI applications for MagSense Finfeed noted this morning that Imagion Biosystems’ (A...
Read ArticleShares in Imagion Biosystems (ASX:IBX) have increased approximately three-fold since June on the bac...
Read ArticleAccording to Imagion Biosystems (ASX:IBX) CEO, Robert Proulx, advancements in imaging have been slow...
Read ArticleThrough the filing of a Pre-Submission with the U.S. Food and Drug Administration (FDA), MedTech com...
Read ArticleImagion Biosystems (ASX:IBX) says it has filed pre-submission with the US Food and Drug Admi...
Read ArticleRemember Orthocell (ASX: OCC), that company gained 377 per cent in a day when it showed Cel-Gro help...
Read ArticleImagion Biosystems (ASX:IBX) has received notification from the FDA's Center for Devices and...
Read ArticleAt Stockhead, we tend to judge a company’s size by its market capitalisation. But a company’s enter...
Read ArticleThe MagSense test aims to eliminate the unnecessary surgeries and concomitant morbidity resulting fr...
Read ArticleMedical tech company Imagion Biosystems (ASX: IBX) has scored a key breakthrough in the development...
Read ArticleImagion Biosystems (ASX: IBX) has received notification from the Center for Devices and Radiological...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleWant to know when shares are coming out of escrow? We’ve been keeping tabs, so you don’t have to. Ev...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
